These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7733144)

  • 1. Southwestern Internal Medicine Conference: high-dose intravenous gamma globulin therapy: how does it work?
    Smiley JD; Talbert MG
    Am J Med Sci; 1995 May; 309(5):295-303. PubMed ID: 7733144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
    Schwab I; Nimmerjahn F
    Nat Rev Immunol; 2013 Mar; 13(3):176-89. PubMed ID: 23411799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
    Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
    Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous and subcutaneous immunoglobulin therapy].
    Thon V
    Epidemiol Mikrobiol Imunol; 2013 Jul; 62(2):64-73. PubMed ID: 23964967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations.
    Ye S; Li D; Liu F; Lei M; Jiang P; Wang Z; Zhang R; Du X; Cao H; Ma L; Li C
    J Pharm Biomed Anal; 2018 Mar; 151():317-323. PubMed ID: 29413980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases.
    Ballow M
    J Allergy Clin Immunol; 1997 Aug; 100(2):151-7. PubMed ID: 9275133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
    Tremblay T; Paré I; Bazin R
    Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
    Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J;
    Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
    Bazin R; Lemieux R; Tremblay T
    Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulins--understanding properties and mechanisms.
    Durandy A; Kaveri SV; Kuijpers TW; Basta M; Miescher S; Ravetch JV; Rieben R
    Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):2-13. PubMed ID: 19883419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous gamma-globulin therapy in bronchial asthma.
    Schwartz HJ; Berger M
    Allergy Asthma Proc; 2002; 23(1):15-8. PubMed ID: 11894729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level.
    Lutz HU; Stammler P; Bianchi V; Trüeb RM; Hunziker T; Burger R; Jelezarova E; Späth PJ
    Blood; 2004 Jan; 103(2):465-72. PubMed ID: 14512320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-directed therapy: past, present, and future.
    Gelfand EW
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S111-6. PubMed ID: 11586277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).
    Kaveri S; Prasad N; Vassilev T; Hurez V; Pashov A; Lacroix-Desmazes S; Kazatchkine M
    Mult Scler; 1997 Apr; 3(2):121-8. PubMed ID: 9291165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of action of immunoglobulin applied intravenously].
    Kasztalska K; Ciebiada M; Górski P
    Pol Merkur Lekarski; 2010 Oct; 29(172):263-8. PubMed ID: 21207645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.
    Burns JC; Franco A
    Expert Rev Clin Immunol; 2015; 11(7):819-25. PubMed ID: 26099344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.